Product Information
NARATRIPTAN HCL 1 MG TABLET is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $1.7764 per EA under NDC 00054027803. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jul 7, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054027803
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NARATRIPTAN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090381FDA Approved
7/7/2010
TE Code
AB
On Market Since
7/7/2010
Pharmacological Classes
Price Statistics
The NADAC for NARATRIPTAN HCL 1 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 65.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7764 per EA |
|---|---|
| All-time high | $5.6187 (Oct 15, 2014) |
| All-time low | $0.8029 (May 22, 2024) |
| 52-week high | $2.1073 |
| 52-week low | $1.5274 |
| Median price | $2.6569 |
| Average price | $3.1518 |
| Largest weekly change | +77.5% (Jan 17, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Naratriptan market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Naratriptan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NARATRIPTAN HCL 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NARATRIPTAN HCL 1 MG TABLET, manufactured by Hikma Pharmaceuticals USA Inc., is $1.7764 per EA (NDC 00054027803), effective Sep 30, 2026.
How has the price of NARATRIPTAN HCL 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for NARATRIPTAN HCL 1 MG TABLET has declined 65.4%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NARATRIPTAN HCL 1 MG TABLET?
Since Nov 28, 2013, the NADAC for NARATRIPTAN HCL 1 MG TABLET has ranged from a low of $0.8029 (May 22, 2024) to a high of $5.6187 (Oct 15, 2014), with a median of $2.6569 per EA.
Are there cheaper alternatives to NARATRIPTAN HCL 1 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of NARATRIPTAN HCL 1 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NARATRIPTAN HCL 1 MG TABLET?
NARATRIPTAN HCL 1 MG TABLET (NDC 00054027803) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.